Another Move to Improve Supply Chain Traceability Comes as Customs Teams With FDA

The FDA and U.S. Customs and Border Protection (CBP) are partnering to promote supply chain traceability and improve the government’s visibility into imports by focusing on Global Business Identifiers (GBI), unique numbers that capture information about legal business entities and their functions within the supply chain.
Source: Drug Industry Daily